The ultimate goal for the use of GRNOPC1 is restore spinal cord function by injecting hESC-derived oligodendrocyte progenitor cells directly into the patient’s injured spinal cord.
FDA OK's Embryonic Stem Cell Therapy
Here's some good news:
Comments